Skip to main content

Pharma News

 

Clinical courses

 

Clinical research courses

Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

  • Rare Disease DNA-Damaging Mutation could have consequences for more common conditions

    TREX1 is a gene that is supposed to direct the maintenance of the entire body DNA, but new research shows that when people are born with mutated TREX1, it causes catastrophic damage to the DNA over time, resulting in a deadly rare disease called retinal vasculopathy with cerebral leukoencephalopathy
  • Oral insulin drops offer relief for diabetes patients
    Pre-clinical tests showed that insulin with the peptide effectively reaches the bloodstream whereas without the peptide, insulin remains stuck in the inside lining of the mouth.
  • Researchers develops novel antibody treatment for Kidney Cancer
    Antibody therapies called bispecific T cell engagers have emerged as effective treatments for some blood cancers but have been more difficult to develop for solid tumors. While clinically successful, first-generation BTEs suffer a short half-life.
  • U.S. Drug-related infant deaths more than doubled in five years
    A new study by Florida Atlantic Universitys Schmidt College of Medicine has uncovered a disturbing trend in drug-related infant deaths in the United States from 2018 to 2022.
  • Scientists discover a novel modulator of human regulatory T cells

    The T cells in our blood fight against cancer, viruses and bacteria. Specific regulatory T cells are required to control faulty immune responses, and disruption in their function may lead to autoimmune diseases or cancer.

  • Engineered DNA 'warhead' targets a common cancer mutation
    Tumour protein P53 (TP53) plays an important role in suppressing the growth of tumours. Mutations in the gene for TP53 can have a disastrous effect, hampering the body's ability to fight tumours and even encouraging their growth. Because these are the most common mutations in cancers, TP53 has long been an interesting therapeutic target. However, efforts to destroy the mutant protein have been hampered by the difficulty of finding a way to bind to it.
  • Heart healthy behaviors may help reverse rapid cell aging

    The benefit of better heart health may be associated with the positive impact of heart healthy lifestyle factors on biological aging (the age of the body and its cells), according to new research published today in the Journal of the American Heart Association, an open access, peer-reviewed journal of the American Heart Association.

  • New study discovers tiny target on RNA to short-circuit inflammation
    This peptide originates from within a long non-coding RNA called LOUP. According to the researchers, the human genome encodes over 20,000 lncRNAs, making it the largest group of genes produced from the genome. But despite this abundance, scientists know little about why lncRNAs exist or what they do
  • Pharma Quality Excellence Awards 2024 : A Night of Elegance and Triumph

    In the glistening ambiance of success and camaraderie, the stage was set for an evening of unparalleled splendor and distinction as the maiden edition of Pharma Quality Excellence Awards 2024 unfolded in all its grandeur. 

  • 4th Annual Pharma GMP & Quality Management 2024

    A Comprehensive Post-Show Review

Subscribe to Pharma News